← Back to catalogue

Phadia Prime System

FDA 510(k)FDA UDIEUDAMED

Class II (US FDA 510(k))

510(k) K151029Ref 12-4101-00

by Phadia AB

Identity

Trade Name
Phadia Prime EUDAMEDFDA UDI
Generic Name
Laboratory instrument/analyser application software IVD FDA UDI
Device Name
Phadia Prime EUDAMEDFDA UDI
Model / Reference
12-4101-00 EUDAMEDFDA UDI
Description
Phadia Prime FDA UDI

Identifiers

Catalog Number
12-4101-00 FDA UDI
Primary DI / UDI-DI
07333066015101 EUDAMEDFDA UDI
Basic UDI-DI
7333066BUDI0016LV EUDAMED
510(k) Number
K151029 FDA 510(k)FDA UDI
FDA Product Code
DHB FDA 510(k)FDA UDI
EMDN Code
W0201020192 AUTOMATED IMMUNOCHEMISTRY ANALYSERS - IVD MEDICAL DEVICE SOFTWARE EUDAMED
GMDN Term
Laboratory instrument/analyser application software IVD FDA UDI

Classification

Device Class
Class A EUDAMED
Class II FDA 510(k)FDA UDI
Legislation / Framework
21 CFR Part 866.5750 FDA 510(k)
Regulation Number
866.5750 FDA 510(k)FDA UDI
Special Device Type
Software EUDAMED
Market of Registration
Sweden EUDAMED
Advisory Committee
Immunology FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

EUDAMEDFDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Microbial Substances

No

EUDAMED

Reagent

No

EUDAMED

Self Testing

No

EUDAMED

Near-Patient Testing

No

EUDAMED

Professional Testing

Yes

EUDAMED

Companion Diagnostics

No

EUDAMED

Surgical Instrument

No

EUDAMED

New Device

No

EUDAMED

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

The Phadia Prime System is an in vitro diagnostic device classified as a Radioallergosorbent Test (RAST) Immunological System. It is designed for the quantitative measurement of specific IgE antibodies in human serum or plasma, enabling the diagnosis and monitoring of allergic conditions such as asthma, hay fever, and food allergies.

This system is supplied as a reagent kit for laboratory use and is intended for single-use only. It operates under in vitro diagnostic regulations, including FDA 510(k) clearance and IVDR compliance, with a classification as a Class II device. The system requires proper storage at controlled temperatures and adherence to manufacturer instructions for handling and disposal to ensure accuracy and reliability.

Frequently asked questions

What types of allergic conditions can the Phadia Prime System help diagnose or monitor?

The Phadia Prime System is designed for the quantitative measurement of specific IgE antibodies in human serum or plasma, which helps in diagnosing and monitoring allergic conditions such as asthma, hay fever (seasonal allergies), and food allergies. By detecting specific IgE levels, clinicians can assess the likelihood of allergic reactions to triggers like pollen, dust mites, or certain foods.

Is the Phadia Prime System intended for single-use or repeated use in a laboratory setting?

The Phadia Prime System is supplied as a reagent kit for laboratory use and is explicitly intended for single-use only. This ensures accuracy and reliability, as reuse could compromise test integrity or introduce contamination risks. Always follow the manufacturer’s instructions for proper handling and disposal.

What storage conditions are required for the Phadia Prime System to maintain its performance?

The Phadia Prime System must be stored under controlled temperatures as specified by the manufacturer. While the exact temperature range isn’t detailed here, proper storage is critical to preserve reagent stability and ensure accurate IgE measurement results. Always refer to the included instructions for precise storage guidelines.

How is the Phadia Prime System regulated, and what does that mean for its use in clinical settings?

The Phadia Prime System holds FDA 510(k) clearance and complies with the In Vitro Diagnostic Regulation (IVDR), classifying it as a Class II device. This means it has undergone regulatory review to demonstrate substantial equivalence to a predicate device and meets safety and performance standards for laboratory use in diagnosing allergic conditions. Clinicians can rely on its compliance for reliable diagnostic support.

Are there multiple versions or sizes of the Phadia Prime System, or does it come as a unified kit?

The Phadia Prime System is supplied as a reagent kit, but the data includes multiple FEI numbers and registration numbers, suggesting it may encompass various allergen-specific test components (e.g., for pollen, food, or environmental allergens). While not explicitly listed as

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Active

IVDR

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Phadia AB

Sources (3)

  • FDA 510(k) K151029 24 fields · synced Sep 18, 2026
  • FDA UDI 10f2a0e3-ab8e-4745-96a5-6572b58be25a 36 fields · synced May 30, 2026
  • EUDAMED 4bf7f4d7-6f56-4c0b-889a-bb7cfff99b73 61 fields · synced Jul 17, 2026